Nouveau Life Pharmaceuticals, Inc.
NOUV · OTC
12/31/2024 | 6/30/2007 | 6/30/2006 | 6/30/2005 | |
|---|---|---|---|---|
| Market Cap | $1 | $9 | $12 | $7 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $9 | $12 | $8 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | -0.013 | -0.01 | -0.017 |
| % Growth | 100% | -27.3% | 40% | – |
| Operating Cash Flow | – | -$0 | -$0 | -$0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | -$0 | -$0 | -$0 |